News & Views
Japanese Market Entry Key to Growth
Apr 26 2022
A key step in its global growth strategy was achieved by CatSci following its expansion into the Japan at the end of March. The step was described as ‘pivotal’ to the company’s ongoing commitment to support pharmaceutical companies worldwide in meeting their CMC demands.
In 2019, CatSci started focusing on international markets with expansion into the EU and US, while continuing to grow in the UK, hiring Dr Jas Douville as Head of Business Development for North America, Dr João Madeira do Ó as Head of Business Development for Europe and Dr Jenny Wallis as Head of Business Development for UK and the Rest of the World.
The move into Japan represented the next of many advancements, which include development of the company’s workforce, laboratories, equipment and offerings as part of a £3m investment plan, the company said.
Dr Ross Burn, CEO at CatSci, said: “We are looking forward to working with our Japanese customers so that they can continue to meet the healthcare needs of the world. This key expansion will support our innovative and ambitious export strategy as we continue our global journey.”
More information online
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Nov 27 2024 Istanbul, Turkey
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE